Paul J. Clancy, Executive VP and CFO at BIOGEN IDEC INC. (BIIB), sold 26,785 shares at $245.00 ($6.6M) on 2013-09-18, disclosed to the SEC on 2013-09-19.
Scheduled sale ($6.6M) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALXN | SELL | 2018-02-08 | $1.4M | — | Filing → |
| BIIB | SELL | 2017-04-27 | $2.9M | — | Filing → |
| BIIB | SELL | 2017-03-14 | $5.8M | — | Filing → |